Top 5 Midcap

1 Deepak Nitrate 12 months 12 months

Total Revenue Mar-31-2019 Mar-31-2020

Gross Profit 23.50% 34.80%

EBITDA 28.80% 49.00%

EBITA 30.80% 53.50%

EBIT 30.90% 53.60%

Earnings from Cont. Ops. 35.30% 63.10%

Net Income 35.30% 63.10%

Normalized Net Income 35.10% 64.60%

Diluted EPS before Extra 28.30% 54.70%

Accounts Receivable 14.50% 14.50%

Inventory 25.90% 30.30%

Net PP&E 26.90% 27.50%

Total Assets 22.60% 23.40%

Tangible Book Value 28.50% 35.40%

28.40% 35.30%
Common Equity 28.40% 35.30%

Cash from Ops. NM 47.90%

Capital Expenditures 20.10% 30.30%

Levered Free Cash Flow NM NM

Unlevered Free Cash Flow NM NM

Dividend per Share 14.90% 35.10%

Stock

12 months 12 months 12 months

Mar-31-2021 Mar-31-2022 Mar-31-2023

34.70% 40.60% 33.90%

49.40% 64.10% 45.40%

53.40% 74.50% 50.20%

53.50% 74.60% 50.30%

65.40% 61.80% 60.90%

65.40% 61.80% 60.90%

63.00% 86.70% 59.70%

57.60% 57.00% 59.80%

19.30% 25.70% 26.00%

25.90% 28.50% 22.40%

26.80% 17.00% 7.40%

22.40% 19.90% 14.60%

37.60% 35.90% 34.50%

37.80% 36.10% 34.70%

37.80% 36.10% 34.70%

43.00% 75.80% 28.80%

19.60% -8.80% -10.40%

68.70% NM NM

56.20% NM NM

30.30% 42.30% 42.00%

Indusry Analysis

The Indian chemical industry is thriving, valued at USD 220 billion

and expected to reach USD 1 trillion by 2040. It ranks 6th globally
and 3rd in Asia, contributing 7% to India's GDP. Key sectors include
specialty chemicals, agrochemicals, and dyes. Chemical production
in May 2023 reached 926.99 million metric tonnes.

Revenue Growth: The company has demonstrated consistent

revenue growth over the years, indicating a healthy top-line
performance.
Profitability: Gross profit, EBITDA, EBITA, and EBIT margins have
generally increased, suggesting improved operational efficiency and
profitability.
Earnings and Net Income: Both earnings from continuing
operations and net income have shown a positive trend, reflecting the
company's ability to generate profits.
Cash Generation: The positive trend in cash from operations is a
good sign, as it indicates the company's ability to generate cash from
its core business activities.
2 UNO MINDA LTD

Total Revenue 28.20% 22.80% 20.40% 19.70%

Gross Profit 39.40% 26.50% 22.00% 19.10%

EBITDA 57.40% 34.80% 23.80% 18.30%

EBITA 93.00% 40.70% 21.70% 17.60%

EBIT 93.10% 38.70% 19.10% 15.80%

Earnings from Cont. Ops. 123.00% 22.60% 15.20% 17.40%

Net Income 108.90% 18.00% 13.20% 16.60%

Normalized Net Income 111.10% 29.80% 17.10% 16.70%

Diluted EPS before Extra 105.60% 14.70% 9.70% 12.80%

Accounts Receivable 27.60% 24.40% 26.80% 22.50%

35.10% 34.10% 34.90% 36.30%

Inventory 35.10% 34.10% 34.90% 36.30%

Net PP&E 33.50% 42.50% 27.70% 21.70%

Total Assets 33.90% 41.10% 32.10% 23.30%

Tangible Book Value 37.10% 28.60% 29.70% 22.80%

Common Equity 40.80% 38.80% 37.00% 26.50%

Cash from Ops. 58.30% 50.60% 18.60% 2.70%

Capital Expenditures 40.60% 52.30% 7.30% 17.80%

Levered Free Cash Flow NM 92.40% NM NM

Unlevered Free Cash Flow NM 79.50% NM NM

Dividend per Share 40.60% 0.00% 12.70% 15.40%

 Share holding

Promoters
20.20%

Mutual funds

Foreign Institution
18.60%

17.80%

17.90%

17.10%

16.20%

Revenue Growth: The company has shown consistent revenue

growth over the years, indicating a healthy top-line
performance.
16.10%
Gross Profit Margin: The gross profit margin has increased
significantly, suggesting improved cost efficiency and
profitability.

EBITDA and EBITA Margins: Both EBITDA and EBITA

margins have shown substantial improvement, indicating strong
operational performance.
18.10%

Net Income Growth: Net income has consistently grown,

reflecting the company's ability to generate profits.

Accounts Receivable: The increase in accounts receivable

may suggest growing sales,
13.80%

16.90%

27.80%
 27.80%

16.70%

19.80%

24.00%

24.50%

17.10%

13.40%

NM

NM

26.30%
 A high promoter stake (68.74%) generally suggests a
68.74 strong alignment of interests between company
management and shareholders.
Mutual funds' significant presence (15.34%) implies
15.34 that professional fund managers find Uno Minda Ltd.
to be an attractive investment.

7.79 Foreign institutional investors' involvement (7.79%)

indicates international interest in the company.
Kajaria Ceramics

Year 2023 2022

Total Revenue 4,415.55 3,732.76
Total Revenue Growth (%) 18.29 33.21
Total Expenses 3,945.10 3,222.59
Total Expenses Growth (%) 22.42 34.87
Profit after Tax (PAT) 344.5 376.98
PAT Growth (%) -8.62 22.38
Operating Profit Margin (%) 11.24 14.11
Net Profit Margin (%) 7.86 10.17
Basic EPS (₹) 21.64 23.69
 2021 2020 2019
2,802.20 2,832.16 2,974.23
-1.06 -4.78 9.29
2,389.46 2,519.71 2,611.36
-5.17 -3.51 10.33
308.05 255.33 226.57
20.65 12.69 -3.57
15.22 11.82 12.8
11.07 9.09 7.66
19.37 16.06 14.25
Provided financial data, the company appears
to be performing well. Positive trends in
revenue, net income, operating margin, and net
profit margin suggest sound financial health.
AU Small fiannce bank

Metric Value
Previous Close 774.3
Open 776.1
High 798.85
Low 768 AU Small Finance Bank exhibit
VWAP 784.27 (ROE) of 13.65%. This in
52 Wk High 798.85
52 Wk Low 548.15 The bank's robust Earnings Per
Upper Price Band 851.70 (10%) healthy bottom
Lower Price Band 696.90 (10%)
The Price to Earnings (PE) ratio
2W Avg Qty (Lakh) 0.93 values the bank's earnings at a
TTQ (Lakh) 0.5 balance b
Turnover (Cr.) 3.9
The stock's consistent trading
Mcap Full (Cr.) 52,753.22 upper and lower price band
Mcap FF (Cr.) 37,982.32 m
Face Value 10
AU Small Finance Bank boasts
EPS (TTM) 24.04 presence in the market. This ca
CEPS (TTM) 24.04 sugges
PE 32.21
PB 4.4
ROE 13.65
U Small Finance Bank exhibits a stable financial performance, with a reasonable Return on Equity
(ROE) of 13.65%. This indicates efficient use of shareholder equity to generate profits.

he bank's robust Earnings Per Share (EPS) of 24.04 reflects strong earnings strength, suggesting a
healthy bottom line and potential for shareholder value creation.

he Price to Earnings (PE) ratio of 32.21 indicates a moderate valuation, suggesting that the market
values the bank's earnings at a reasonable multiple. This may be attractive to investors seeking a
balance between growth potential and current valuation.

The stock's consistent trading patterns, as indicated by the 52-week high and low, along with the
upper and lower price bands, provide investors with insights into the stock's historical price
movements, aiding in risk management.

U Small Finance Bank boasts a strong market capitalization of ₹52,753.22 Cr., indicating a sizable
resence in the market. This can instill confidence in investors, as larger market capitalization often
suggests a more established and stable company.
Apollo Hospital

Apollo Hospitals Enterprises

Consolidated Profit & ------------------- in Rs. Cr. -------------------
Mar '23 Mar '22 Mar '21 Mar '20

12 mths 12 mths 12 mths 12 mths

Income
Sales Turnover 16,612.45 14,662.60 10,560.00 11,246.80
Net Sales 16,612.45 14,662.60 10,560.00 11,246.80
Other Income 90.34 372.3 105.6 225.2
Stock Adjustments 24.54 73.3 125.2 107
Total Income 16,727.33 15,108.20 10,790.80 11,579.00
Expenditure
Raw Materials 8,598.77 4,961.30 4,186.10 3,796.70
Power & Fuel Cost 0 178.2 156.1 194.6
Employee Cost 2,143.78 1,786.50 1,601.00 1,852.90
Other Manufacturing E 0 2,685.50 1,623.30 1,809.20
Selling and Admin Exp 0 364.8 199.8 227.1
Miscellaneous Expense 3,844.83 2,574.50 1,781.50 1,886.00
Total Expenses 14,587.38 12,550.80 9,547.80 9,766.50
Mar '23 Mar '22 Mar '21 Mar '20

12 mths 12 mths 12 mths 12 mths

Operating Profit 2,049.61 2,185.10 1,137.40 1,587.30

PBDIT 2,139.95 2,557.40 1,243.00 1,812.50
Interest 380.79 378.6 449.2 532.8
PBDT 1,759.16 2,178.80 793.8 1,279.70
Depreciation 615.24 600.7 573.1 619.7
Profit Before Tax 1,143.92 1,578.10 220.7 660
PBT (Post Extra-ord Ite 1,143.92 1,578.10 220.7 660
Tax 256.2 477 84.7 225.2
Reported Net Profit 887.72 1,048.30 149.6 457.9
Minority Interest 25.5 0 0 0
Share Of P/L Of Associ 43.15 -7.3 -0.8 3.1
Net P/L After Minority 819.07 814.3 76.2 233.4
Total Value Addition 5,988.61 7,589.50 5,361.70 5,969.80
Equity Dividend 0 43.7 38.3 129.1
Corporate Dividend Tax 0 0 0 26.4
Per share data (annualised)
Shares in issue (lakhs) 1,437.80 1,437.85 1,437.85 1,391.25
Earning Per Share (Rs 61.74 72.91 10.4 32.91
Book Value (Rs) 431.02 391.09 319.67 239.79
 APOLLO is a market leader in terms of stock price, sales, and profitability.
Mar '19

12 mths its seems growth prospects stock for investor in a future

9,617.44 APOLLOHOSP has the highest last traded price among the peers, indicating
9,617.44 The percentage change in APOLLOHOSP's stock price is in line with its pee
31.44
71.56
9,720.44 APOLLOHOSP's 52-week high/low range is wide, indicating significant price
MAXHEALTH and MEDANTA also have substantial ranges, while NH has a
3,087.55
170.61
1,598.24 APOLLOHOSP has the highest sales and profitability (PAT) among the pee
1,644.88 MEDANTA has the lowest sales and PAT among the four.
183.88
1,940.18
8,625.34 APOLLOHOSP has a relatively lower equity and face value compared to NH
Mar '19 MEDANTA has a significantly lower equity and a different face value compa

12 mths
Apollo Hospitals demonstrates a positive financial performance, with consist
1,063.66 The company's ability to manage operating expenses and maintain profitabi
1,095.10 The focus on reinvesting earnings instead of distributing dividends may sugg
327.02
768.08
395.53
372.55
372.55
173.37
235.07
0
-0.98
200.17
5,537.79
69.56
 14.16

1,391.25
16.9
239.4
ck price, sales, and profitability.

tor in a future

price among the peers, indicating a higher valuation.

's stock price is in line with its peers, suggesting comparable market sentiment.

s wide, indicating significant price fluctuation during the period.

ubstantial ranges, while NH has a comparatively narrower range.

profitability (PAT) among the peers, indicating strong financial performance.

among the four.

y and face value compared to NH and MAXHEALTH.

and a different face value compared to other peers.

nancial performance, with consistent growth in sales, profitability, and per-share metrics.
g expenses and maintain profitability reflects effective cost management strategies.
of distributing dividends may suggest a strategy of capital reinvestment for future growth.